SZSE Ticker: 300255

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

河北常山生化药业股份有限公司

常山药业

CHANGSHAN PHARMA

Listing Date: 2011-08-19

Board: GEM

Industry Classification: Manufacturing

A-share capital face daily: 19 shares have received financing for a net purchase of over 50 million! Financiers are optimistic about buying 2 shares, accounting for over 30% of the transaction

Post date May 13, 2022 — 17:25 Post Lock

Changshan Pharmaceutical (300255): Resolution of Changshan Pharmaceutical's 2021 Annual General Meeting of Shareholders CFi.CN

Post date May 11, 2022 — 21:42 Post Lock

Medical beauty concept stocks fluctuated lower

Post date April 27, 2022 — 11:10 Post Lock

Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net

Post date April 26, 2022 — 18:07 Post Lock

Unexplained hepatitis broke out in many countries, concept stocks with high performance growth were released, and funds from the north increased their positions in two stocks – yqqlm

Post date April 25, 2022 — 19:46 Post Lock

A shares fell sharply and the Shanghai index was close to 3,000 points, and this sector bucked the market and rose to the red! Unknown source of acute hepatitis hit, the company's performance soared 237% Stock Channel Teller Report

Post date April 25, 2022 — 14:16 Post Lock

A-share heparin concept change, Qianhong Pharmaceutical rushes to the daily limit, and the industry leader has different performances?

Post date April 25, 2022 — 14:06 Post Lock

Changshan Pharmaceutical: Enoxaparin Sodium Injection Obtained Cuban Drug Registration Certificate Finance and Economics

Post date April 13, 2022 — 18:26 Post Lock

Changshan Pharmaceutical: Enoxaparin Sodium Injection Obtained Cuban Drug Registration Certificate_Oriental Fortune Network

Post date April 13, 2022 — 18:26 Post Lock

Changshan Pharmaceutical (300255): Changshan Pharmaceutical obtained Uzbekistan Drug Registration Certificate for Heparin Sodium Injection CFi.CN

Post date April 13, 2022 — 18:21 Post Lock

Changshan Pharmaceutical (300255): Changshan Pharmaceutical obtained the Cuban Drug Registration Certificate for Enoxaparin Sodium Injection CFi.CN Zhongcai Net

Post date April 13, 2022 — 18:21 Post Lock

Junshi Bio-Toripalimab Receives Orphan Drug Designation for Small Cell Lung Cancer and BeiGene Approves Second-Line Treatment for Esophageal Squamous Cell Carcinoma

Post date April 13, 2022 — 18:17 Post Lock

Announcement Express of Listed Companies in the Evening of April 13_Sina Finance_Sina.com

Post date April 13, 2022 — 18:15 Post Lock

Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month _ Securities Times

Post date April 7, 2022 — 09:25 Post Lock

Northbound capital Masukura list: 35 shares increased by more than 20% month-on-month – yqqlm

Post date April 7, 2022 — 09:20 Post Lock